Skip to main content

Determinants and management of polycystic ovary syndrome

Guest Editor

Noha M. Shawky, PhD, University of Mississippi Medical Center, United States
 

BMC Endocrine Disorders called for submissions to our Collection on Determinants and management of polycystic ovary syndrome. Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects millions of people worldwide. Despite being one of the most common hormonal disorders, there are still many aspects of PCOS that remain poorly understood. This Collection aimed to provide a platform for risk factors and treatment of PCOS.


New Content ItemThis Collection supports and amplifies research related to  SDG 3: Good Health & Wellbeing and SDG 5: Gender Equality.

Meet the Guest Editor

Back to top

Noha M. Shawky, PhD, University of Mississippi Medical Center, United States

Dr Noha M. Shawky (Elsayed) is an Assistant Professor at the Department of Pharmacology in University of Mississippi Medical Center. Her lab is interested in studying the mechanisms behind the sex differences in the cardiovascular consequences of maternal hyperandrogenemia on offspring as adults and when they age. Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age women and is the major cause of hyperandrogenemia in women. It is not clear whether offspring born under conditions of maternal hyperandrogenemia (as seen in maternal PCOS) are at risk of hypertension and cardiovascular diseases or not. Understanding those risks could lead to potential earlier intervention for offspring born to hyperandrogenemic females.

About the Collection

BMC Endocrine Disorders called for submissions to our Collection on Determinants and management of polycystic ovary syndrome. Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects millions of people worldwide. Despite being one of the most common hormonal disorders, there are still many aspects of PCOS that remain poorly understood. This Collection aimed to provide a platform for risk factors and treatment of PCOS.

We welcomed submissions on a wide range of topics related to PCOS, including but not limited to: 

  • Epidemiology and genetic predisposition of PCOS
  • Pathophysiology and hormonal mechanisms
  • Clinical manifestations and diagnostic criteria
  • Novel imaging techniques and biomarkers for diagnosis
  • Management strategies for PCOS-related infertility
  • Lifestyle interventions and dietary management
  • Pharmacological treatments and hormonal therapies
  • Psychological aspects and quality of life in PCOS patients
  • Long-term health consequences and comorbidities
  • Patient-centered care and holistic approaches
  • In vivo models of PCOS
  • Impact of maternal PCOS on offspring long-term health

Image credit: © sewcream / Stock.adobe.com

  1. The relationship between the triglyceride glucose (TyG) index and the incidence of depression in populations with polycystic ovary syndrome (PCOS) remains unclear. This study aims to investigate the relationsh...

    Authors: Guili Chen, Lin Zhu, Ying Lou, Yingyun Wu, Lanying Wang, Weirong Mao and Jianting Ma
    Citation: BMC Endocrine Disorders 2025 25:108
    Content type: Research Published on:

  2. We aimed to analyze the clinical features, treatment, and prognosis of Wilson disease (WD) combined with polycystic ovary syndrome (PCOS), and to explore the correlation between endocrine abnormalities and liv...

    Authors: Lin Chen, Ming-juan Fang, Liang-liang Zhang, Yong-feng Liu, Yong-zhu Han, Xu-en Yu and Yin Xu
    Citation: BMC Endocrine Disorders 2025 25:78
    Content type: Research Published on:

  3. Hydroxychloroquine (HCQ) is frequently utilized in rheumatic immune disorders and has been discovered to exert hypoglycemic effects in some obese women with polycystic ovary syndrome(PCOS), however, the precis...

    Authors: Ruihan Wang, Shanqin Qi, Qi Wang, Jiajia Lang, Conghui Pang and Kehua Wang
    Citation: BMC Endocrine Disorders 2025 25:2
    Content type: Research Published on:

  4. Many patients with polycystic ovary syndrome (PCOS) also experience thyroid disorders. There is a notable similarity in energy metabolism among PCOS, C1q/tumor necrosis factor (TNF)-related proteins (CTRP-5)de...

    Authors: Fatima Abdul-ameer, Itlal Jummha AbudlRasool AlAsadi, Asieh Hosseini and Elham Bahreini
    Citation: BMC Endocrine Disorders 2024 24:272
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Determinants and management of polycystic ovary syndrome" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.